HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized Trial

Journal of General Internal Medicine

Volumn 33, Issue 7, 2018, Pages 1077-1083

  Carrasquillo, Olveen ^a   Seay, Julia ^a   Amofah, Anthony ^b   Pierre, Larry ^c   Alonzo, Yisel ^a   McCann, Shelia ^b   Gonzalez, Martha ^a   Trevil, Dinah ^a   Koru Sengul, Tulay ^a   Kobetz, Erin ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Health Choice Network   (United States)

^c Center for Haitian Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURAL FACTOR; ETHNIC GROUP; FEMALE; FLORIDA; FOLLOW UP; HAITIAN; HEALTH AUXILIARY; HEALTH CARE FACILITY; HEALTH EDUCATION; HISPANIC; HUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SELF EVALUATION; SELF REPORT; UTERINE CERVIX CANCER; DIAGNOSTIC KIT; EARLY CANCER DIAGNOSIS; EDUCATION; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CENTER; ISOLATION AND PURIFICATION; MIDDLE AGED; MINORITY GROUP; PAPILLOMAVIRIDAE; PROCEDURES; SELF CARE; SINGLE BLIND PROCEDURE; UTERINE CERVIX TUMOR;

ADULT; AGED; COMMUNITY HEALTH CENTERS; EARLY DETECTION OF CANCER; ETHNIC GROUPS; FEMALE; FLORIDA; HUMANS; MIDDLE AGED; MINORITY GROUPS; PAPILLOMAVIRIDAE; REAGENT KITS, DIAGNOSTIC; SELF CARE; SINGLE-BLIND METHOD; UTERINE CERVICAL NEOPLASMS;

EID: 85044463401     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-018-4404-z     Document Type: Article

References (27)

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2016. Available at: www.cdc.gov/uscs. Accessed February 2, 2018
2. Beavis, AL, Gravitt PE, Rositch AF. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer 2017;123:1044–1050
3. Musselwhite W, Oliveira CM, Kwaramba T, et al. Racial/ethnic disparities in cervical cancer screening and outcomes. Acta Cytologica 2016;60:518–526
4. Lin L, Benard VB, Greek A, Hawkins NA, Roland KB, Saraiya M. Racial and ethnic differences in human papillomavirus positivity and risk factors among low-income women in Federally Qualified Health Centers in the United States. Prev Med. 2015;81:258–61
5. Seay JS, Carrasquillo O, Campos NG, McCann S, Amofah A, Pierre L, et al. Cancer screening utilization among immigrant women in Miami, Florida. Progress in Community Health Partnerships: Research, Education, and Action. 2015;9 Suppl:11–20
6. Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse populations. Gynecologic Oncology 2008;109;S22–S30
7. O’Brien MJ, Halbert CH, Bixby R, Susana Pimentel S, Shea J. Community health worker intervention to decrease cervical cancer disparities in Hispanic women. J Gen Intern Med. 2010; 25: 1186–1192
8. National Cancer Institute. Research-tested Intervention Programs (RTIPs): cervical cancer Available from: https://rtips.cancer.gov/rtips/programSearch.do Accessed February 2, 2018
9. Community Preventive Services Task Force. Updated recommendations for client- and provider-oriented interventions to increase breast, cervical, and colorectal cancer screening. Am J Prev Med 2012;43:760–4
10. Ronco G, Dillner J, Elfström KM, et al: Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials. Lancet 2014;383:524–32
11. Jeronimo J, Castle PE, Temin S et al. Secondary prevention of cervical cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Glob Oncol 2017;3:635–657
12. US Food and Drug Administration. Meeting materials of the microbiology devices panel. 12 March 2014. FDA, Bethesda, MD. https://wayback.archive-it.org/7993/20170113191702/http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MicrobiologyDevicesPanel/UCM388564.pdf. Accessed February 2, 2018
13. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15:172–83
14. Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X, et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer. 2012;130:1855–60
15. Racey CS, Withrow DR, Gesink D: Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health 2013;104:e159-e166
16. Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening program by offering self-sampling kits: a systematic review and meta-analysis of randomized trials. Eur J Cancer. 2015;51:2375–85
17. Barbee L, Kobetz E, Menard J, Cook N, Blanco J, Barton B, et al. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes & Control. 2010;21:421–31
18. Castle PE, Rausa A, Walls T, Gravitt PE, Partridge EE, Olivo V, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med 2011;52:452–55
19. Ilangovan K, Erin Kobetz E, Koru-Sengul T, et al. Acceptability and feasibility of human papilloma virus self-sampling for cervical cancer screening. Journal Women’s Health 2016;25: 944–51
20. Sewali B, Okuyemi KS, Askhir A, et al. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial. Cancer Med. 2015;4: 620–631
21. Carrasquillo O, McCann S, Amofah A, et al. Rationale and Design of the Research Project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS): study protocol for a randomized controlled trial. Trials. 2014;15:e299
22. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U.S. know about human papillomavirus (HPV) and cervical cancer? Cancer Epidemiology, Biomarkers, and Prevention, 2007;16:288–94
23. Hariri S, Unger ER, Strenberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006. J Infect Dis 2011:204:566–573
24. Lazcano-Ponce E, Lorincz A, Cruz-Valdez et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomized controlled trial. Lancet 2011: 378;1868–1873
25. Arrossi S, Thouyaret L, Herrero R, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomized trial. Lancet Glob Health, 2015;3:e85–94
26. Montaño DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. American Journal of Public Health 1995:85;795–800
27. Han JJ, Beltran TH, Song JW. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men National Health and Nutrition Examination Survey (NHANES) 2013-2014. JAMA Oncol 2017;3:810–816